Bassani C - Search Results

1

Loss of Circulating CD8+ CD161^high T Cells in Primary Progressive Multiple Sclerosis.

Acquaviva M, Bassani C, Sarno N, Dalla Costa G, Romeo M, Sangalli F, Colombo B, Moiola L, Martinelli V, Comi G, Farina C. Acquaviva M, et al. Among authors: bassani c. Front Immunol. 2019 Aug 14;10:1922. doi: 10.3389/fimmu.2019.01922. eCollection 2019. Front Immunol. 2019. PMID: 31474991 Free PMC article.

2

Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration.

Colombo E, Bassani C, De Angelis A, Ruffini F, Ottoboni L, Comi G, Martino G, Farina C. Colombo E, et al. Among authors: bassani c. Front Immunol. 2020 Apr 8;11:635. doi: 10.3389/fimmu.2020.00635. eCollection 2020. Front Immunol. 2020. PMID: 32322257 Free PMC article.

3

Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes.

Colombo E, Triolo D, Bassani C, Bedogni F, Di Dario M, Dina G, Fredrickx E, Fermo I, Martinelli V, Newcombe J, Taveggia C, Quattrini A, Comi G, Farina C. Colombo E, et al. Among authors: bassani c. Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2025804118. doi: 10.1073/pnas.2025804118. Proc Natl Acad Sci U S A. 2021. PMID: 34183414 Free PMC article.

4

Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation.

Colombo E, Pascente R, Triolo D, Bassani C, De Angelis A, Ruffini F, Ottoboni L, Comi G, Martino G, Farina C. Colombo E, et al. Among authors: bassani c. Molecules. 2020 Nov 18;25(22):5403. doi: 10.3390/molecules25225403. Molecules. 2020. PMID: 33218208 Free PMC article.

5

Vascular impairment in patients with primary biliary cirrhosis.

Marasini B, Pipia C, DeValle G, Crosignani A, Petroni L, Cugno M, Zeni S, Bruno S, Bassani C. Marasini B, et al. Among authors: bassani c. Int J Microcirc Clin Exp. 1995 Mar-Apr;15(2):75-9. doi: 10.1159/000178953. Int J Microcirc Clin Exp. 1995. PMID: 8655255

6

Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon.

Marasini B, Cugno M, Bassani C, Stanzani M, Bottasso B, Agostoni A. Marasini B, et al. Among authors: bassani c. Int J Microcirc Clin Exp. 1992 Nov;11(4):375-82. Int J Microcirc Clin Exp. 1992. PMID: 1459797

7

L-arginine therapy in Raynaud's phenomenon?

Agostoni A, Marasini B, Biondi ML, Bassani C, Cazzaniga A, Bottasso B, Cugno M. Agostoni A, et al. Among authors: bassani c. Int J Clin Lab Res. 1991;21(2):202-3. doi: 10.1007/BF02591645. Int J Clin Lab Res. 1991. PMID: 1815764

8

Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.

Marasini B, Bassani C. Marasini B, et al. Among authors: bassani c. Br J Clin Pharmacol. 1990 Dec;30(6):847-51. doi: 10.1111/j.1365-2125.1990.tb05450.x. Br J Clin Pharmacol. 1990. PMID: 2288831 Free PMC article.

9

DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects.

Marasini B, Cugno M, Bassani C, Fabrizi I, Bottasso B, Agostoni A. Marasini B, et al. Among authors: bassani c. Thromb Haemost. 1992 Nov 10;68(5):621. Thromb Haemost. 1992. PMID: 1455411 No abstract available.

10

Increased plasma endothelin levels in patients with Raynaud's phenomenon.

Biondi ML, Marasini B, Bassani C, Agastoni A. Biondi ML, et al. Among authors: bassani c. N Engl J Med. 1991 Apr 18;324(16):1139-40. N Engl J Med. 1991. PMID: 2008192 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page